HIV | Page 42 of 51 | SpiritIndia.com

HIV :: 24-week results from Aptivus, tipranavir

Data from two 24-week analyses of the RESIST-1 and RESIST-2 studies, which evaluated Aptivus? (tipranavir) in treatment-experienced HIV-1 infected patients, were published in the 15 November issue of Clinical Infectious Diseases. Data demonstrate that at 24-weeks Aptivus, used with ritonavir (Aptivus/r) as part of combination antiretroviral therapy, achieved superior antiviral and immunological activity in treatment-experienced patients with multidrug-resistant HIV-1 infection.

HIV :: New HIV statistics indicate increasing toll of AIDS on African-American community

The country’s leading African-American lawmakers, civil rights leaders and medical experts today called on the federal government to adopt and implement a new blueprint to address the HIV/AIDS crisis in the African-American community.

HIV :: Massachusetts To Record HIV Patients’ Names

AIDS Action Committee of Massachusetts, Inc. today announced its opposition to the Public Health Council’s adoption of a regulation requiring providers to report cases of HIV infection by name to the Department of Public Health, instead of the code that has been in use since 1999.

HIV :: A More Convenient HIV Treatment Is as Effective as More Complex Regimens

Regimens to treat HIV infection that are based on a non-nucleoside reverse transcriptase inhibitor (NNRTI) are at least as effective as treatment with a protease inhibitor but require patients to take fewer pills each day, according to a new study funded in part by HHS? Agency for Healthcare Research and Quality.

HIV :: No link found between erectile medications and HIV

Erectile dysfunction (ED) medications known as Phosphodiesterase type 5 (PDE-5) inhibitors have been used by millions of men as safe and effective management options associated with high rates of patient and partner satisfaction.

HIV :: Adolescent arrest history influences risk of acquiring HIV

Adolescents with a history of arrest are at greater risk for HIV infection than adolescents with no arrest history, according to a new study published in the November issue of Drug and Alcohol Dependence. Researchers from the Bradley Hasbro Children’s Research Center and Brown Medical School attribute higher rates of substance abuse, sexual risk behaviors and mental-health issues to the increased risk of infection.

HIV :: HIV infection linked to chronic lung disease

New research shows that patients who are HIV positive may be at an increased risk for developing chronic obstructive pulmonary disease (COPD).

HIV :: Progress made in HIV vaccine development

Researchers have successfully tested two candidate vaccines that may eventually be used together to confer immunity against HIV infection. Their findings are published in the Dec. 15 issue of the Journal of Infectious Diseases, now available online.

HIV :: To slow AIDS in Russia, treat HIV-positive addicts – Stanford study

The key to combating AIDS in Russia may be to treat HIV-infected drug users. A new model estimating the spread of HIV in Russia suggests that treating injection drug users with antiretroviral medication will slow transmission of the virus among the general population.

HIV :: New AIDS therapy nukes HIV with radioactive antibodies – Targeted Irradiation

Antiretroviral therapy can keep HIV infection in check and delay and ameliorate the symptoms of HIV/AIDS. However, the drugs do not manage to eradicate the virus completely; individuals have to stay on the drugs permanently. Preclinical studies in mice by Ekatarina Dadachova and colleagues (Albert Einstein College of Medicine) published in the international open-access journal PLoS Medicine now suggest a new strategy to locate and kill many if not all HIV-infected cells in the body.